Restylane Refyne and Restylane Defyne are dermal fillers injected under the facial skin. Once injected, the products help smooth away the wrinkles and folds that may form around the sides of a patient’s nose and corners of the mouth, according to a news release.
Restylane Refyne was approved to treat moderate to severe facial wrinkles and Restylane Defyne was approved to treat deeper facial wrinkles.
Fort Worth, Texas-based Galderma developed the products.
More articles on supply chain:
JHL Biotech signs $236M biosimilar deal with Sanofi
Naloxone price hikes could hurt efforts to reduce opioid-related deaths in US
Trump administration will likely repeal Medical Device Tax: 5 takeaways
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
